ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 46 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $50,000 | +47.1% | 50,200 | 0.0% | 0.00% | – |
| Q1 2016 | $34,000 | -44.3% | 50,200 | 0.0% | 0.00% | – |
| Q4 2015 | $61,000 | -45.5% | 50,200 | 0.0% | 0.00% | – |
| Q3 2015 | $112,000 | -4.3% | 50,200 | 0.0% | 0.00% | – |
| Q2 2015 | $117,000 | +8.3% | 50,200 | 0.0% | 0.00% | – |
| Q1 2015 | $108,000 | -6.1% | 50,200 | 0.0% | 0.00% | – |
| Q4 2014 | $115,000 | -14.2% | 50,200 | 0.0% | 0.00% | – |
| Q3 2014 | $134,000 | -28.3% | 50,200 | 0.0% | 0.00% | – |
| Q2 2014 | $187,000 | -68.3% | 50,200 | 0.0% | 0.00% | -100.0% |
| Q1 2014 | $590,000 | +41.5% | 50,200 | +0.4% | 0.00% | 0.0% |
| Q4 2013 | $417,000 | -10.1% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $464,000 | -5.3% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $490,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|